146 related articles for article (PubMed ID: 9663729)
1. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
Piscaglia F; Gaiani S; Siringo S; Gramantieri L; Serra C; Bolondi L
Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
[TBL] [Abstract][Full Text] [Related]
2. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Bolognesi M; Sacerdoti D; Merkel C; Gatta A
J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
[TBL] [Abstract][Full Text] [Related]
3. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
[TBL] [Abstract][Full Text] [Related]
4. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
[TBL] [Abstract][Full Text] [Related]
5. Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
Tincani E; Cioni G; Cristani A; D'Alimonte P; Vignoli A; Abbati G; Ventura P; Romagnoli R; Ventura E
J Ultrasound Med; 1993 Sep; 12(9):525-9. PubMed ID: 8107184
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
[TBL] [Abstract][Full Text] [Related]
7. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
Piscaglia F; Donati G; Gaiani S; Gramantieri L; Leoni S; Mancini M; Bolondi L
Dig Liver Dis; 2004 Sep; 36(9):594-602. PubMed ID: 15460844
[TBL] [Abstract][Full Text] [Related]
8. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
Orban Schiopu AM; Balas BI; Diculescu M
Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
[TBL] [Abstract][Full Text] [Related]
9. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
10. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
Stanley AJ; Bouchier IA; Hayes PC
Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
[TBL] [Abstract][Full Text] [Related]
12. Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation.
Forrest EH; Jalan R; Redhead DN; Hayes PC
Aliment Pharmacol Ther; 1996 Oct; 10(5):795-800. PubMed ID: 8899089
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
Escorsell A; Bordas JM; Feu F; García-Pagán JC; Ginès A; Bosch J; Rodés J
Gastroenterology; 1997 Nov; 113(5):1640-6. PubMed ID: 9352867
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
[TBL] [Abstract][Full Text] [Related]
15. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
[TBL] [Abstract][Full Text] [Related]
19. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
García-Pagán JC; Morillas R; Bañares R; Albillos A; Villanueva C; Vila C; Genescà J; Jimenez M; Rodriguez M; Calleja JL; Balanzó J; García-Durán F; Planas R; Bosch J;
Hepatology; 2003 Jun; 37(6):1260-6. PubMed ID: 12774003
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
